The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 01, 2013

Filed:

Apr. 16, 2008
Applicants:

Jun LI, Princeton, NJ (US);

James J. LI, Pennington, NJ (US);

Stephen P. O'connor, Princeton, NJ (US);

Haixia Wang, Columbus, NJ (US);

Lawrence J. Kennedy, Titusville, NJ (US);

Jeffrey A. Robl, Newtown, PA (US);

Lawrence G. Hamann, North Grafton, MA (US);

Inventors:

Jun Li, Princeton, NJ (US);

James J. Li, Pennington, NJ (US);

Stephen P. O'Connor, Princeton, NJ (US);

Haixia Wang, Columbus, NJ (US);

Lawrence J. Kennedy, Titusville, NJ (US);

Jeffrey A. Robl, Newtown, PA (US);

Lawrence G. Hamann, North Grafton, MA (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/495 (2006.01);
U.S. Cl.
CPC ...
Abstract

Novel compounds are provided which are 1 1-beta-hydroxysteroid dehydrogenase type I inhibitors. 1 1-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 1 1-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: W-L-Z or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein W, L are defined herein and Z is selected from the following bicyclic heteroaryl groups: (a), (b), (c), (d).


Find Patent Forward Citations

Loading…